+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single Injection, Three Injection, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5440498
The global viscosupplementation market size is expected to reach USD 9.14 billion by 2030 and is expected to grow at a CAGR of 9.58% from 2023 to 2030. The market growth is driven by several key factors, including a rise in the elderly population, an increase in osteoarthritis cases among older individuals, and substantial investments in research and development. According to the CDC, approximately 25% of adults in the United States currently experience some type of arthritis, and this number is expected to reach 78 million by 2040. As a result, the demand for viscosupplementation is predicted to surge in the coming years.

Furthermore, the market growth is being propelled by the increasing adoption of key strategies, such as acquisition, agreement, collaboration, and partnership, by companies. For instance, in December 2021, Avanos Medical, a medical technology company, acquired OrthogenRx, Inc., a trailblazer in viscosupplementation therapy for knee osteoarthritis treatment. The acquisition amounted to approximately USD 160 billion. Avanos utilizes FDA-approved products, such as TriVisc and GenVisc850, to provide effective solutions in this field. Moreover, favorable reimbursement policies with respect to the geriatric population are expected to act as an opportunity for market growth.

Over the past few years, there has been a remarkable increase in the number of orthopedic surgeons in developing nations like South Korea, Russia, and China. This trend indicates significant growth potential in the Asia Pacific region, which boasts a large patient population and untapped opportunities when compared to the United States. Consequently, the introduction of new products by market players in Asian countries is anticipated to drive further growth in the market.

Viscosupplementation Market Report Highlights

  • The three-injection product segment dominated the market with a share of over 43.1% in 2022 and is expected to continue its dominance throughout the forecast period
  • The single-injection product is relatively new in the market with many medtech companies undertaking clinical trials for the approval of their single and three injection services
  • The orthopedic clinics/ASCs end-use segment held the largest share in 2022 due to ease of facilities and administrations, and technological upgradations. Their facilities, which provide outpatient services, remain more feasible for the geriatric population. The segment is expected to continue its dominance throughout the forecast period
  • Asia Pacific dominated the market and accounted for the largest revenue share of 45.57% in 2022 due to its large geriatric population
  • Europe is anticipated to register the fastest CAGR of around 10.7% over the forecast period due to medical advancements and the presence of untapped opportunities. The region is also forecasted to witness a growth in its geriatric population, resulting in more cases of osteoarthritis

Table of Contents

Chapter 1 Methodology and Scope
1.1. Research Process
1.2. Information Procurement
1.2.1. Purchased database:
1.2.1.1. internal database
1.2.2. Market Formulation & Validation
1.3. Research Methodology
1.4. Research Scope and Assumptions
1.5. Research Methodology
1.5.1. Region Market: CAGR Calculation
1.5.2. Region-Based Segment Share Calculation
1.6. List of Data Sources
Chapter 2 Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Viscosupplementation Market Snapshot
Chapter 3 Viscosupplementation Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Viscosupplementation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of Substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on the Viscosupplementation Market
Chapter 4 Viscosupplementation Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Viscosupplementation Market: Product Movement Analysis, USD Million, 2022 & 2030
4.2.1. Single Injection
4.2.1.1. Single Injection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.2.2. Three Injection
4.2.2.1. Three Injection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.2.3. Five Injection
4.2.3.1. Five Injection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Viscosupplementation Market: End-use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Viscosupplementation Market: End-use Movement Analysis, USD Million, 2022 & 2030
5.2.1. Hospitals
5.2.1.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
5.2.2.1. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Viscosupplementation Market: Regional Estimates & Trend Analysis
6.1. Definition & Scope
6.2. Regional Market Share Analysis, 2022 & 2030
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
6.5.1. North America
6.5.1.1. North America Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.2. U.S.
6.5.1.2.1. Key Country Dynamics
6.5.1.2.2. Competitive Scenario
6.5.1.2.3. Regulatory Framework
6.5.1.2.4. Reimbursement Scenario
6.5.1.2.5. U.S. Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.3. Canada
6.5.1.3.1. Key Country Dynamics
6.5.1.3.2. Competitive Scenario
6.5.1.3.3. Regulatory Framework
6.5.1.3.4. Reimbursement Scenario
6.5.1.3.5. Canada Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2. Europe
6.5.2.1. Europe Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.2. UK
6.5.2.2.1. Key Country Dynamics
6.5.2.2.2. Competitive Scenario
6.5.2.2.3. Regulatory Framework
6.5.2.2.4. Reimbursement Scenario
6.5.2.2.5. UK Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.3. Germany
6.5.2.3.1. Key Country Dynamics
6.5.2.3.2. Competitive Scenario
6.5.2.3.3. Regulatory Framework
6.5.2.3.4. Reimbursement Scenario
6.5.2.3.5. Germany Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.4. France
6.5.2.4.1. Key Country Dynamics
6.5.2.4.2. Competitive Scenario
6.5.2.4.3. Regulatory Framework
6.5.2.4.4. Reimbursement Scenario
6.5.2.4.5. France Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.5. Italy
6.5.2.5.1. Key Country Dynamics
6.5.2.5.2. Competitive Scenario
6.5.2.5.3. Regulatory Framework
6.5.2.5.4. Reimbursement Scenario
6.5.2.5.5. Italy Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.6. Spain
6.5.2.6.1. Key Country Dynamics
6.5.2.6.2. Competitive Scenario
6.5.2.6.3. Regulatory Framework
6.5.2.6.4. Reimbursement Scenario
6.5.2.6.5. Spain Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.7. Denmark
6.5.2.7.1. Key Country Dynamics
6.5.2.7.2. Competitive Scenario
6.5.2.7.3. Regulatory Framework
6.5.2.7.4. Reimbursement Scenario
6.5.2.7.5. Denmark Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.8. Sweden
6.5.2.8.1. Key Country Dynamics
6.5.2.8.2. Competitive Scenario
6.5.2.8.3. Regulatory Framework
6.5.2.8.4. Reimbursement Scenario
6.5.2.8.5. Sweden Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.9. Norway
6.5.2.9.1. Key Country Dynamics
6.5.2.9.2. Competitive Scenario
6.5.2.9.3. Regulatory Framework
6.5.2.9.4. Reimbursement Scenario
6.5.2.9.5. Norway Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Asia Pacific
6.5.3.1. Asia Pacific Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3.2. Japan
6.5.3.2.1. Key Country Dynamics
6.5.3.2.2. Competitive Scenario
6.5.3.2.3. Regulatory Framework
6.5.3.2.4. Reimbursement Scenario
6.5.3.2.5. Japan Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3.3. India
6.5.3.3.1. Key Country Dynamics
6.5.3.3.2. Competitive Scenario
6.5.3.3.3. Regulatory Framework
6.5.3.3.4. Reimbursement Scenario
6.5.3.3.5. India Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3.4. China
6.5.3.4.1. Key Country Dynamics
6.5.3.4.2. Competitive Scenario
6.5.3.4.3. Regulatory Framework
6.5.3.4.4. Reimbursement Scenario
6.5.3.4.5. China Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3.5. Australia
6.5.3.5.1. Key Country Dynamics
6.5.3.5.2. Competitive Scenario
6.5.3.5.3. Regulatory Framework
6.5.3.5.4. Reimbursement Scenario
6.5.3.5.5. Australia Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3.6. Thailand
6.5.3.6.1. Key Country Dynamics
6.5.3.6.2. Competitive Scenario
6.5.3.6.3. Regulatory Framework
6.5.3.6.4. Reimbursement Scenario
6.5.3.6.5. Thailand Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3.7. South Korea
6.5.3.7.1. Key Country Dynamics
6.5.3.7.2. Competitive Scenario
6.5.3.7.3. Regulatory Framework
6.5.3.7.4. Reimbursement Scenario
6.5.3.7.5. South Korea Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. Latin America
6.5.4.1. Latin America Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4.2. Brazil
6.5.4.2.1. Key Country Dynamics
6.5.4.2.2. Competitive Scenario
6.5.4.2.3. Regulatory Framework
6.5.4.2.4. Reimbursement Scenario
6.5.4.2.5. Brazil Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4.3. Mexico
6.5.4.3.1. Key Country Dynamics
6.5.4.3.2. Competitive Scenario
6.5.4.3.3. Regulatory Framework
6.5.4.3.4. Reimbursement Scenario
6.5.4.3.5. Mexico Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4.4. Argentina
6.5.4.4.1. Key Country Dynamics
6.5.4.4.2. Competitive Scenario
6.5.4.4.3. Regulatory Framework
6.5.4.4.4. Reimbursement Scenario
6.5.4.4.5. Argentina Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. MEA
6.5.5.1. MEA Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5.2. South Africa
6.5.5.2.1. Key Country Dynamics
6.5.5.2.2. Competitive Scenario
6.5.5.2.3. Regulatory Framework
6.5.5.2.4. Reimbursement Scenario
6.5.5.2.5. South Africa Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5.3. Saudi Arabia
6.5.5.3.1. Key Country Dynamics
6.5.5.3.2. Competitive Scenario
6.5.5.3.3. Regulatory Framework
6.5.5.3.4. Reimbursement Scenario
6.5.5.3.5. Saudi Arabia Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5.4. UAE
6.5.5.4.1. Key Country Dynamics
6.5.5.4.2. Competitive Scenario
6.5.5.4.3. Regulatory Framework
6.5.5.4.4. Reimbursement Scenario
6.5.5.4.5. UAE Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5.5. Kuwait
6.5.5.5.1. Key Country Dynamics
6.5.5.5.2. Competitive Scenario
6.5.5.5.3. Regulatory Framework
6.5.5.5.4. Reimbursement Scenario
6.5.5.5.5. Kuwait Viscosupplementation Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1. Company Categorization
7.2. Key Company Market Position Analysis
7.3. Key Company Market Share Analysis
7.4. Recent Development and Impact Analysis, by Key Market Participants
7.5. Company Profiles
7.5.1. Sanofi
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Anika Therapeutics, Inc.
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Seikagaku Corporation
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Zimmer Biomet
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Smith & Nephew PLC
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Ferring Pharmaceutical B.V.
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Lifecore Biomedical, LLC (Landec)
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. LG Life Sciences Ltd.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Fidia Farmaceutici S.p.A
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. F.Hoffmann-La Roche Ltd.
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 North America Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 5 U.S. Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 6 U.S. Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 8 Canada Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 10 Europe Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 11 U.K. Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 U.K. Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 13 Germany Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 14 Germany Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 France Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16 France Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 17 Italy Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 18 Italy Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Spain Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20 Spain Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21 Sweden Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 22 Sweden Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 Denmark Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24 Denmark Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 25 Norway Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 26 Norway Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 29 Japan Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 30 Japan Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31 China Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 China Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 33 India Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 34 India Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Australia Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 36 Australia Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 37 South Korea Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 38 South Korea Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 Thailand Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 41 Latin America Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 42 Latin America Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 43 Brazil Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 44 Brazil Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 45 Mexico Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 46 Mexico Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Argentina Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 Argentina Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 49 MEA Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 50 MEA Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 51 South Africa Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 South Africa Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 55 UAE Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 UAE Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 57 Kuwait Viscosupplementation market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 58 Kuwait Viscosupplementation market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Viscosupplementation market snapshot (2022)
Fig. 9 Viscosupplementation market segmentation
Fig. 10 Market trends and outlook
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Viscosupplementation Market, by Product : key takeaways (USD Million)
Fig. 16 Viscosupplementation market: product movement analysis, 2022 & 2030 (USD Million)
Fig. 17 Single injection estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Three injection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Five injection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Viscosupplementation market, end-use outlook: key takeaways (USD Million)
Fig. 21 Viscosupplementation market: end-use movement analysis, 2022 & 2030 (USD Million)
Fig. 22 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Orthopedic Clinics/Ambulatory Surgical Centers (ASCS) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Viscosupplementation market, regional marketplace: Key takeaways (USD Million)
Fig. 25 Viscosupplementation market: regional movement analysis, 2021 & 2030 (USD Million)
Fig. 26 North America Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 U.S. Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Canada Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Germany Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 UK Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 France Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Spain Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Italy Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Sweden Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Denmark Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Norway Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Japan Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 China Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 India Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Australia Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 South Korea Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Thailand Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Latin America Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Brazil Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Mexico Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Argentina Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 MEA Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 South Africa Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Saudi Arabia Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 UAE Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Kuwait Viscosupplementation market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Sanofi
  • Anika Therapeutics, Inc.
  • SEIKAGAKU CORPORATION
  • Zimmer Biomet
  • Smith & Nephew PLC
  • Ferring Pharmaceutical B.V.
  • Lifecore Biomedical, LLC (Landec)
  • LG Life Sciences Ltd.
  • Fidia Farmaceutici S.p.A
  • F.Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...

Table Information